Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19
Detection Principle
Mixed
Target
Myxovirus resistance protein A (MxA) and C reactive protein (CRP)
Testing Method Category
Testing Method
FebriDx
Testing Method - Additional Info
detection of the antiviral host response protein MxA using the FebriDx point-of-care test
Reported Performance
Specificity: 86%; Overall accuracy: 90%; detection for identification of COVID-19: 93%
Sample Size
248 (118 positive por rt-pcr)
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements